OTRK is the Next SPRT Meme Short Squeeze Stock

Back in May we outlined SPRT as the top short squeeze stock when it was trading at only $2.68. 














We were largely ignored and censored on the WSB Reddit page because SPRT didn't meet market cap requirements. Well now SPRT is popular AFTER people after put their money in at $50 and may be losing as the stock pulled back after its major squeeze. You win on the stock market by being the FIRST one into the meme stocks, not the last. The next major meme squeeze is Ontrak, Inc. (OTRK). We think it will hit $20 in the coming weeks but can't rule out a higher price as stocks like SPRT, GME and AMC show that the sky is the limit on heavily shorted stocks. 

This would not be the first time we called a squeeze on OTRK. On March 4, we announced it as a top short squeeze candidate. That was the day it closed at a low of $24.39. In two weeks it was trading as high as $39. Great money can be made on stock and call options if a similar move was to occur again.  

This is OTRK's share statistics according to Yahoo Finance:














There are 1.75 million shares short on a float of 9.19 million, for a short interest % of 19%. This is comparable to other short squeeze meme darlings like AMC, GME and MVIS. OTRK recently tanked on bad news. While it has been recovering, the recovery has been slowed by the insider selling of former CEO but current Chairman Terren Peizer. He has been selling a few thousand shares each day since the stock tanked in mid-August but still owns over 9.4 million shares. People think this is bad news, so the stock has had problems rebounding strongly. This is where things get interesting and we think it's actually good news that he's selling. If he wants out, he obviously wants out at the highest price possible. It would be in Peizer's best interest if OTRK went on a run like SPRT's. 

We will say this as generally as possible without tying any specific actions to any specific people. People with a vested interest in seeing OTRK move up could infiltrate WSB Reddit or "convince" (wink, wink) top contributors in the group to push the OTRK short squeeze narrative. Giving award stickers to posters on Reddit doesn't cost a lot of money compared to the money that can be made on a short squeeze by those who own a large position. Keep a close eye on OTRK. It will squeeze sooner rather than later and don't be surprised to see it as a WSB darling like SPRT is very soon. Take it from us, who predicted SPRT would be a top short squeeze candidate when it was trading near its 52-week lows of $2.68, not near its highs. 

Comments

  1. G.August 29, 2021 at 11:18 AM

    Thanks for your post, will have an eye on OTRK

    ReplyDelete
  2. UnknownAugust 29, 2021 at 7:37 PM

    Great info! Do you post on other sites besides the blog WSB blog? Thanks!

    ReplyDelete
  3. G.August 30, 2021 at 7:54 AM

    Seems like you hit something here ;)

    ReplyDelete
  4. MichaelSeptember 2, 2021 at 10:50 AM

    i just got me some stocks in that

    ReplyDelete

Post a Comment

Popular posts from this blog

The Two Best Biotech Short Squeeze Candidates And The Next Carvana

Image
With the market having recovered most of its recent drop to be near all-time highs once again, shorts have been destroyed and are in a desperate spot. Heavily shorted stocks like B. Riley Financial, Inc. (RILY), Globe Life Inc. (GL) and Carvana Co. (CVNA) have been on absolute tears. We have written about CVNA before , as well as the impact of CVNA's move on Root , Inc. (ROOT). When a stock is squeezing like CVNA, a related stock like ROOT will follow suit. Shorts are often shorting multiple related stocks. Most don't even hide it with Kerrisdale openly bragging about its poor track record. GL was another one that was attacked by shorts which we talked about as a gamma squeeze candidate that has worked out very well over the past three weeks.  In this market of short squeezes, we have identified two excellent biotech short squeeze candidates, ImmunityBio, Inc. (IBRX) and Soleno Therapeutics, Inc. (SLNO). IBRX is starting up the production and sale of its cancer drug ANKT...
Read more

The Next NVDA-Backed Runner and New Asian IPO Squeeze Play

Image
We have seen stocks like Super Micro Computer, Inc. (SMCI) and SoundHound AI, Inc. (SOUN) have incredible squeeze runs thanks to their connection to NVIDIA Corporation (NVDA). We think the next one will be Spire Global, Inc. (SPIR), which popped a week ago after it announced a collaboration with NVDA to enhance AI-driven weather prediction. A few day later it dropped on the announcement of a financing at $14, with the potential to raise $61 million if warrants at $14.50 are exercised. We think there is a good chance that NVDA got in on this financing, as it tends to invest in the companies it does these deals with when spreading AI across different sectors. One such recent example was with Recursion Pharmaceuticals, Inc. (RXRX) for AI in drug development.  It looks like SPIR didn't really need this financing as it has enough cash and looks like it will be cash flow and net income positive in 2024. This financing was of a strategic nature, not something led by broker...
Read more

Forget about CVNA, PLCE is the Next Major Short Squeeze Play

Image
 Back in June, we called out Kerrisdale Capital and its short on Carvana Co. (CVNA) in our piece " Carvana: The Gamma Squeeze is Real, Time to Bankrupt Kerrisdale ". Kerrisdale has a history of calling one bad short after another, creating a squeeze on all of its positions as the firm and its associates face liquidity crises. Kerrisdale is once again on a cold streak as its short on Altimmune, Inc. (ALT) simultaneously blew up just as CVNA headed from $70 to $80 this week.  However, we think CVNA is done for now. Recall that in June after the initial spike to nearly $30, the stock pulled back to $20 before hitting $40 in the next month. People who are riding weekly call options aren't likely to cash in. CVNA looks headed to the mid to low $60's to close the gap that currently exists in the $62 to $66 area before resuming any further rise. Kerrisdale created an artificial short squeeze with its report, but now that both ALT and CVNA have come down from their weekly hig...
Read more